OXBDF (Oxford BioMedica) Change In Inventory: $-2.5 Mil (TTM As of Dec. 2025)

What is Oxford BioMedica Change In Inventory?

Oxford BioMedica OXBDF 72 Change In Inventory is $-2.5 Mil as of Dec. 2025. GuruFocus rates OXBDF with a GF Score™ of 72/100 and a GF Value™ of $7.12 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Oxford BioMedica's change in inventory for the quarter that ended in Dec. 2025 was $0.2 Mil. It means Oxford BioMedica's inventory declined by $0.2 Mil from Jun. 2025 to Dec. 2025 .

Oxford BioMedica's change in inventory for the fiscal year that ended in Dec. 2025 was $-2.5 Mil. It means Oxford BioMedica's inventory increased by $2.5 Mil from Dec. 2024 to Dec. 2025 .

Oxford BioMedica's Total Inventories for the quarter that ended in Dec. 2025 was $23.2 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Oxford BioMedica's Days Inventory for the quarter that ended in Dec. 2025 was 49.41.

Inventory Turnover measures how fast the company turns over its inventory within a year. Oxford BioMedica's Inventory Turnover for the quarter that ended in Dec. 2025 was 3.69.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Oxford BioMedica's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.17.

Oxford BioMedica (OTCPK:OXBDF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Oxford BioMedica's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	22.1795	/	81.921	*	365 / 2
	=	49.41

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Oxford BioMedica's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	81.921	/	22.1795
	=	3.69

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Oxford BioMedica's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	22.1795	/	127.869
	=	0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford BioMedica Change In Inventory Related Terms

Oxford BioMedica Change In Inventory Historical Data

* Premium members only.

The historical data trend for Oxford BioMedica's Change In Inventory can be seen below:

Oxford BioMedica Change In Inventory Chart

Oxford BioMedica Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Change In Inventory

Get a 7-Day Free Trial

-3.47

0.81

-0.31

2.77

-2.47

Oxford BioMedica Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Change In Inventory	Get a 7-Day Free Trial															0.85	-1.02	3.79	-2.74	0.23

72GF Score

Oxford BioMedica PLC OXBDF

Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Oxford BioMedica Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-2.5 Mil.

Frequently Asked Questions Learn more about Change In Inventory →

What does a Change In Inventory of $-2.5 Mil mean?

Oxford BioMedica (OXBDF) has a Change In Inventory of $-2.5 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Oxford BioMedica and its competitors.

Is Oxford BioMedica's Change In Inventory too high?

Oxford BioMedica's current Change In Inventory is $-2.5 Mil. Overall, Oxford BioMedica has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Oxford BioMedica's Change In Inventory compare to VRTX and REGN?

Oxford BioMedica's Change In Inventory of $-2.5 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Inventory for a Biotechnology company?

A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Inventory mean?

A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Oxford BioMedica and its competitors. Oxford BioMedica's current Change In Inventory is $-2.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Oxford BioMedica stock overvalued right now?

Based on GuruFocus' analysis, Oxford BioMedica (OXBDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $7.12, compared to a current price of $7.99 — trading 12.2% above its estimated fair value. The current Change In Inventory is $-2.5 Mil. Oxford BioMedica's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Inventory calculated?

Change In Inventory is calculated from a company's financial statements. For Oxford BioMedica (OXBDF), the current Change In Inventory is $-2.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oxford BioMedica (OXBDF) Overvalued in 2026?

Based on GuruFocus' analysis, Oxford BioMedica stock appears to be overvalued. The current stock price of $7.99 is trading 12.2% above its estimated GF Value™ of $7.12. GuruFocus considers Oxford BioMedica to be Modestly Overvalued.

Key valuation signals for OXBDF:

Change In Inventory: $-2.5 Mil
GF Value™: $7.12 vs. price of $7.99 (12.2% above fair value)
GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the OXBDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oxford BioMedica Business Description

Industry Healthcare Biotechnology

Comparable Companies LSE:AVCT LSE:IBT LSE:ONT LSE:PRTC LSE:SCLP LSE:GNS LSE:BVXP LSE:FARN LSE:4BB LSE:HEMO VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges OXBl:UK OXB:UK OXO:Germany

Address Transport Way, Windrush Court, Oxford, GBR, OX4 6LT

Website https://www.oxb.com

Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, adeno-associated virus (AAV), adenovirus, and other viral vector types. Geographically, it derives maximum revenue from the United States, and the rest from Europe, the UK, and the Rest of the world.

72GF Score

Get the complete analysis for OXBDF

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.99

Price

$7.12

GF Value

View OXBDF Analysis

See Change In Inventory data for all stocks →